|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cohen P: The role of protein
phosphorylation in human health and disease. The Sir Hans Krebs
Medal Lecture. Eur J Biochem. 268:5001–5010. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hinds TD Jr and Sánchez ER: Protein
phosphatase 5. Int J Biochem Cell Biol. 40:2358–2362. 2008.
View Article : Google Scholar
|
|
5
|
Golden T, Aragon IV, Rutland B, Tucker JA,
Shevde LA, Samant RS, Zhou G, Amable L, Skarra D and Honkanen RE:
Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human
breast cancer. Biochim Biophys Acta. 1782:259–270. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shirato H, Shima H, Nakagama H, Fukuda H,
Watanabe Y, Ogawa K, Matsuda Y and Kikuchi K: Expression in
hepatomas and chromosomal localization of rat protein phosphatase 5
gene. Int J Oncol. 17:909–912. 2000.PubMed/NCBI
|
|
7
|
Golden T, Aragon IV, Zhou G, Cooper SR,
Dean NM and Honkanen RE: Constitutive over expression of
serine/threonine protein phosphatase 5 (PP5) augments
estrogen-dependent tumor growth in mice. Cancer Lett. 215:95–100.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ren W, Wang X, Gao L, Li S, Yan X, Zhang
J, Huang C, Zhang Y and Zhi K: MiR-21 modulates chemosensitivity of
tongue squamous cell carcinoma cells to cisplatin by targeting
DCD4. Mol Cell Biochem. 390:253–262. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu J, Luo JH, Pang J, Cao JZ, Wu RH, Tong
ZT, Chen W and Xie D: Lentivirus-mediated RNA interference of
clusterin enhances the chemosensitivity of EJ bladder cancer cells
to epirubicin in vitro. Mol Med Rep. 6:1133–1139. 2012.PubMed/NCBI
|
|
10
|
Peter S, Borkowska E, Drayton RM, Rakhit
CP, Noon A, Chen W and Catto JW: Identification of differentially
expressed long noncoding RNAs in bladder cancer. Clin Cancer Res.
20:5311–5321. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matsuda K, Takahashi A, Middlebrooks CD,
Obara W, Nasu Y, Inoue K, Tamura K, Yamasaki I, Naya Y, Tanikawa C,
et al: Genome-wide association study identified SNP on 15q24
associated with bladder cancer risk in Japanese population. Hum Mol
Genet. 24:1177–1184. 2015. View Article : Google Scholar
|
|
12
|
Draaken M, Knapp M, Pennimpede T, Schmidt
JM, Ebert AK, Rösch W, Stein R, Utsch B, Hirsch K, Boemers TM, et
al: Genome-wide association study and meta-analysis identify ISL1
as genome-wide significant susceptibility gene for bladder
exstrophy. PLoS Genet. 11:e10050242015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Swingle MR, Honkanen RE and Ciszak EM:
Structural basis for the catalytic activity of human
serine/threonine protein phosphatase-5. J Biol Chem.
279:33992–33999. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Golden T, Swingle M and Honkanen RE: The
role of serine/threonine protein phosphatase type 5 (PP5) in the
regulation of stress-induced signaling networks and cancer. Cancer
Metastasis Rev. 27:169–178. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morita K, Saitoh M, Tobiume K, Matsuura H,
Enomoto S, Nishitoh H and Ichijo H: Negative feedback regulation of
ASK1 by protein phosphatase 5 (PP5) in response to oxidative
stress. EMBO J. 20:6028–6036. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Malik R, Khan AP, Asangani IA, Cieślik M,
Prensner JR, Wang X, Iyer MK, Jiang X, Borkin D, Escara-Wilke J, et
al: Targeting the MLL complex in castration-resistant prostate
cancer. Nat Med. 21:344–352. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang Y, Pan XW, Li L, Chen L, Liu X, Lu
JL, Zhu XM, Huang H, Yang QW, Ye JQ, et al: Overexpression of USP39
predicts poor prognosis and promotes tumorigenesis of prostate
cancer via promoting EGFR mRNA maturation and transcription
elongation. Oncotarget. 7:22016–22030. 2016.PubMed/NCBI
|
|
19
|
Pan XW, Chen L, Hong Y, Xu DF, Liu X, Li
L, Huang Y, Cui LM, Gan SS, Yang QW, et al: EIF3D silencing
suppresses renal cell carcinoma tumorigenesis via inducing G2/M
arrest through downregulation of Cyclin B1/CDK1 signaling. Int J
Oncol. 48:2580–2590. 2016.PubMed/NCBI
|
|
20
|
ter Brake O, Konstantinova P, Ceylan M and
Berkhout B: Silencing of HIV-1 with RNA interference: A multiple
shRNA approach. Mol Ther. 14:883–892. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bank A, Dorazio R and Leboulch P: A phase
I/II clinical trial of beta-globin gene therapy for
beta-thalassemia. Ann NY Acad Sci. 1054:308–316. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Manilla P, Rebello T, Afable C, Lu X,
Slepushkin V, Humeau LM, Schonely K, Ni Y, Binder GK, Levine BL, et
al: Regulatory considerations for novel gene therapy products: A
review of the process leading to the first clinical lentiviral
vector. Hum Gene Ther. 16:17–25. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Menon SG and Goswami PC: A redox cycle
within the cell cycle: Ring in the old with the new. Oncogene.
26:1101–1109. 2007. View Article : Google Scholar
|
|
24
|
Amati B, Alevizopoulos K and Vlach J: Myc
and the cell cycle. Front Biosci. 3:d250–d268. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Abukhdeir AM and Park BH: P21 and p27:
Roles in carcinogenesis and drug resistance. Expert Rev Mol Med.
10:e192008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dickinson RJ and Keyse SM: Diverse
physiological functions for dual-specificity MAP kinase
phosphatases. J Cell Sci. 119:4607–4615. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rovida E and Stecca B: Mitogen-activated
protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk
providing therapeutic opportunities? Semin Cancer Biol. 35:154–167.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang YL and Dong C: MAP kinases in immune
responses. Cell Mol Immunol. 2:20–27. 2005.PubMed/NCBI
|
|
30
|
Low HB and Zhang Y: Regulatory Roles of
MAPK phosphatases in cancer. Immune Netw. 16:85–98. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shah BH and Catt KJ: Protein phosphatase 5
as a negative key regulator of Raf-1 activation. Trends Endocrinol
Metab. 17:382–384. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
von Kriegsheim A, Pitt A, Grindlay GJ,
Kolch W and Dhillon AS: Regulation of the Raf-MEK-ERK pathway by
protein phosphatase 5. Nat Cell Biol. 8:1011–1016. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Han X, Xu B, Beevers CS, Odaka Y, Chen L,
Liu L, Luo Y, Zhou H, Chen W, Shen T, et al: Curcumin inhibits
protein phosphatases 2A and 5, leading to activation of
mitogen-activated protein kinases and death in tumor cells.
Carcinogenesis. 33:868–875. 2012. View Article : Google Scholar : PubMed/NCBI
|
